STEM -- StemCells, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : STEM -- StemCells, Inc.

STEM 15.29

-6.2%

1:49 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Edscharp who wrote (353)	1/23/2000 3:58:00 PM
From: John Soileau	Read Replies (1) of 805

True it is pre-clinical, but IMO milestones along the way will keep interest up. Successful animal studies would propel the stock bigtime. The important thing is that CTII appears to have grabbed a key position in what will emerge over the next 5 years as one of the hottest, most promising fields in medicine. Harvesting, expansion, and guided stimulation of autologous stem cells, then replacement in the body....that's ultimately going to rid us of some diseases afflicting populations in the tens of millions. I think the market is willing to price future events into the stock-- hey, look at the future earnings currently assumed and priced into Yahoo? I think the odds of CTII getting a piece of the clinical pie are at least as good. A final point--as CTII progresses, they will be more and more valuable to a potential suitor. The big pharmas won't want to be left out of this party and they have huge bucks for acquisitions/licensing deals. What do you think of CTII as a potential acquisition target in the nearer term? John

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next